Medical treatment of the disease is usually with somatostatin analogs. An open, prospective, single-center study by Maiza et al. examined the long term (≤18 years) antihormonal and antitumor ...

Treatment of nonfunctioning neuroendocrine tumors with somatostatin analogs has been controversial, given the low antitumor effects of these drugs. The PROMID study group now reports that ...

Inhibiting the hormone somatostatin may be a new treatment ... The current study, which is published in the journal Nature Metabolism, presents a new potential treatment strategy against dangerous ...